Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
92.50    0.00 (0.00%)
Bid:
90.00
Ask:
95.00
Spread: 5.00 (5.556%)
Market Cap: £6.08m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Director/PDMR Shareholding

18 Nov 2016 09:45

RNS Number : 5209P
Crimson Tide PLC
18 November 2016
 

 

CRIMSON TIDE PLC

 

("Crimson Tide" or "the Company")

 

Exercise of Options

 

Crimson Tide announces that certain of its directors yesterday exercised options over 6,000,000 ordinary shares of 0.1p each in the Company ("Ordinary Shares") under the Company's EMI Share Option Scheme.

 

On 17 November 2016 Steve Goodwin, Finance Director, exercised options over 5,000,000 Ordinary Shares at an exercise price of 1.5p per share. Following the exercise, Mr Goodwin holds 30,611,484 Ordinary Shares and also has an interest as a trustee in 9,150,000 Ordinary Shares, representing, in aggregate, 8.77% of the issued share capital.

 

On 17 November 2016 Luke Jeffrey, Technical Director, exercised options over 1,000,000 Ordinary Shares at an exercise price of 1.5p per share. Following the exercise, Mr Jeffrey holds 1,061,890 Ordinary Shares, or 0.23% of the issued share capital.

 

The new Ordinary Shares issued pursuant to the exercise of options will rank pari passu with the existing Crimson Tide Ordinary Shares. Application has been made for the 6,000,000 shares to be admitted to AIM and admission is expected to take place on or around 24 November 2016.

 

The total number of shares in issue following the issue of these shares will be 453,486,234. Crimson Tide has no shares in Treasury, therefore this figure may be used by Shareholders, from Admission, as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

 

Crimson Tide plc

 Barrie Whipp 01892 542 444

 Steve Goodwin

 

W.H. Ireland Limited

 James Joyce / 020 7220 1666

 James Bavister

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Steve Goodwin

2

Reason for the notification

a)

Position/status

Finance Director, Crimson Tide plc

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Crimson Tide plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.1p each

 

 

GB0002080082

b)

Nature of the transaction

Exercise of share options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 1.5p

5,000,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

5,000,000

1.5p

e)

Date of the transaction

17 November 2016

f)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Luke Jeffrey

2

Reason for the notification

a)

Position/status

Technical Director, Crimson Tide plc

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Crimson Tide plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.1p each

 

 

GB0002080082

b)

Nature of the transaction

Exercise of share options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 1.5p

1,000,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

1,000,000

1.5p

e)

Date of the transaction

17 November 2016

f)

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHAKODBNBDBPDD
Date   Source Headline
4th Jan 20235:00 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSDirector dealing
17th Nov 20227:00 amRNSSignificant contract expansion and extension
27th Sep 20227:00 amRNSInterim Results
25th Aug 20227:00 amRNSDirector Dealing
3rd Aug 20227:00 amRNSChange of Auditor
2nd Aug 20227:00 amRNSBoard Changes
25th Jul 20227:00 amRNSContract Win
19th Jul 20227:00 amRNSMultiyear contract win with major wholesaler
30th Jun 202211:27 amRNSResults of AGM & Statement
16th Jun 20224:30 pmRNSAnnual Report and Notice of AGM
7th Apr 20227:00 amRNSPreliminary Results
10th Feb 20227:00 amRNSContract Win and Strategic Partnership
3rd Feb 20227:00 amRNSTrading Update
7th Dec 20217:00 amRNSMaster Service Agreement with Compass Group
12th Nov 20217:00 amRNSDirectorate Change
11th Oct 202110:59 amRNSPDMR Dealing
28th Sep 20217:00 amRNSInterim Results
29th Jun 20213:08 pmRNSResult of AGM
16th Jun 20217:00 amRNSNorth America Appointment
4th Jun 20217:00 amRNSAnnual Report and Notice of AGM
4th May 20212:22 pmRNSTotal Voting Rights
28th Apr 202110:34 amRNSHolding(s) in Company
27th Apr 20217:00 amRNSHolding(s) in Company
26th Apr 20217:00 amRNSHolding(s) in Company
23rd Apr 20214:25 pmRNSHolding(s) in Company
23rd Apr 202110:37 amRNSPDMR Dealings
23rd Apr 202110:36 amRNSHolding(s) in Company
22nd Apr 202111:45 amRNSResult of General Meeting and Total Voting Rights
20th Apr 20217:00 amRNSContract Win
1st Apr 20213:52 pmRNSResult of Placing
1st Apr 202112:01 pmRNSPlacing to raise up to £6.0 million
1st Apr 202112:00 pmRNSPreliminary Results
18th Mar 20217:00 amRNSContract Win
1st Feb 20219:28 amRNSHolding(s) in Company
28th Jan 20217:00 amRNSAppointment of Director
26th Jan 20217:00 amRNSPilot with World Federation of Haemophilia
18th Jan 20219:36 amRNSHolding(s) in Company
12th Jan 20214:07 pmRNSHolding(s) in Company
7th Jan 20212:30 pmRNSHolding(s) in Company
23rd Dec 202012:15 pmRNSClarification re Grant of Options
22nd Dec 202010:45 amRNSGrant of Options under the Company's EMI Scheme
4th Dec 202011:35 amRNSHolding(s) in Company
17th Nov 20207:00 amRNSContract Wins
12th Nov 20204:27 pmRNSDirector/PDMR Shareholding
6th Nov 20201:15 pmRNSPDMR dealing
26th Oct 202010:08 amRNSHolding(s) in Company
5th Oct 20209:16 amRNSHolding(s) in Company
18th Sep 20207:00 amRNSInterim Results
14th Sep 20202:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.